Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The impact of this launch can be assessed through prescription trends, adoption rates in clinical practice, and its role within existing diabetes management frameworks
The LEAD-6 trial demonstrated liraglutides superior glycemic control and tolerability compared to exenatide [37]
(2018) 97:e13087
frequency (how many of these doses per week) is set by the phase you are in, covered in the schedule and titration sections
US$ 27.55
US$ 28.96
US$ 25.91
